Answers are grounded in this paper and cite their sources.
Cohort study shows increased odds of positive margins in stage III colon cancer associated with MSI, suggesting need for neoadjuvant treatments and quality improvement initiatives.
This US cohort study confirmed prior European work suggesting MSI is associated with higher odds of positive margins in stage III colon cancer. Notwithstanding the limitations of a retrospective database, these findings suggest the need for quality improvement initiatives, including the evaluation of neoadjuvant treatments to mitigate this risk.
No takes yet. Share an insight, caveat, or question.
Troester et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: